EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Treace Medical Concepts's Enterprise Value is $335.3 Mil.
Treace Medical Concepts's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-38.4 Mil. Therefore, Treace Medical Concepts's EV-to-FCF for today is -8.72.
The historical rank and industry rank for Treace Medical Concepts's EV-to-FCF or its related term are showing as below:
TMCI'
s EV-to-FCF Range Over the Past 10 Years
Min: -397.58 Med: -28.13 Max: -6
Current: -8.72
During the past 5 years, the highest EV-to-FCF of Treace Medical Concepts was -6.00. The lowest was -397.58. And the median was -28.13.
TMCI's EV-to-FCF is ranked worse than 100% of 358
companies
in the Medical Devices & Instruments industry
Industry Median: 26.625
vs TMCI: -8.72
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Treace Medical Concepts's EV-to-FCF
For the Medical Devices subindustry, Treace Medical Concepts's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Treace Medical Concepts's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Treace Medical Concepts's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Treace Medical Concepts's EV-to-FCF falls into.
Treace Medical Concepts's current Enterprise Value is $335.3 Mil.
Treace Medical Concepts's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-38.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Treace Medical Concepts (NAS:TMCI) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Treace Medical Concepts's PE Ratio for today is calculated as:
Treace Medical Concepts's share price for today is $6.05.
Treace Medical Concepts's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.882.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Treace Medical Concepts EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Treace Medical Concepts's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Treace Medical Concepts (Treace Medical Concepts) Business Description
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMCI has been successfully added to your 